We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 31, 2020

A Meta-Analysis of SGLT2 Inhibitors and All-Cause Mortality

Diabetes, Obesity & Metabolism

 

Additional Info

Diabetes, Obesity & Metabolism
SGLT2 Inhibitors and All-Cause Mortality: A Meta-Analysis of Randomized Controlled Trials
Diabetes Obes Metab 2020 Dec 07;[EPub Ahead of Print], SG Antonio, M Matteo, M Edoardo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading